How Animal Biology Is Shaping The Future of Medicine

Why It Matters

Cross‑species biology could dramatically shorten anti‑aging drug development, delivering multi‑disease benefits and reshaping pharma investment in longevity therapeutics.

Key Takeaways

• Animal gene therapies accelerate human longevity research via companion pets.
• Hibernating species reveal mechanisms to reverse heart and metabolic damage.
• Fauna Bio uses AI and comparative genomics to discover novel targets.
• Rejuvenate Bio's dog trials show multi‑organ health improvements.
• Partnerships with pharma aim to translate metabolic insights into drugs.

Summary

The video explores how evolutionary biology and animal models—particularly companion‑animal gene therapy and hibernation physiology—are being leveraged to accelerate longevity research for humans.

Rejuvenate Bio is testing AAV‑based gene therapies in dogs, reporting restored cardiac function, delayed renal decline, and improved metabolic health, while Fauna Bio applies AI‑driven comparative genomics to translate extreme mammalian traits into therapeutic targets. The discussion highlights ground‑squirrel metabolism shifting from 1 % to 3 % of normal in an hour and spiny mice that fully regenerate heart, skin, and spinal tissue.

A memorable quote from the panelist likens a squirrel surviving “25 heart attacks in six months” to a human model, underscoring the value of natural disease reversal. The partnership with Eli Lilly aims to capture the squirrel’s rapid metabolic rebound to overcome GLP‑1 weight‑loss plateaus and muscle loss.

If these cross‑species insights can be translated into safe human drugs, they promise multi‑organ disease mitigation, faster de‑risking of candidates, and a new paradigm where animal biology directly informs anti‑aging therapeutics, attracting major pharma investment.

Original Description

Sponsor: Fatty15

Fatty15 is a science-backed, patented, award-winning supplement with pure C15:0 that strengthens cell membranes and supports healthy aging at the cellular level. Benefits include deeper sleep, calmer mood, improved energy, and overall wellbeing.

Click the link below to learn more and use code UNLOCKED for 15% off the 90-day Starter Kit.

Link: https://partners.fatty15.com/UNLOCKED

______________________

Guests:

Ashley Zehnder

CEO, Fauna Bio

Linkedin: https://www.linkedin.com/in/ashley-zehnder-31950827/

Website: https://www.faunabio.com/

Daniel Oliver

Co-Founder & CEO, Rejuvenate Bio

Linkedin: https://www.linkedin.com/in/danielcoliver/

Website: https://rejuvenatebio.com/

______________________

What if the animal kingdom holds the key to improving human healthspan and performance?

Phil Newman and Dr. Nina Patrick sit down with Ashley Zehnder, CEO of Fauna Bio, and Daniel Oliver, CEO of Rejuvenate Bio, to explore how insights from hibernating animals, long-lived species, and regenerative models are shaping next-generation longevity therapies. From metabolic adaptations and ketone utilization to epigenetic reprogramming, they reveal how studying other species can guide interventions for human health, recovery, and overall wellness.

Together they explain how species that naturally resist disease, survive extreme conditions, or regenerate tissues provide a roadmap for interventions in humans. From hibernating mammals that switch to ketone-based metabolism to long-lived rodents showing epigenetic resilience, these insights are shaping therapies that target recovery, metabolism, and overall wellness.

They also discuss how these discoveries could inform practical strategies for human health, from personalized nutrition and exercise to novel drug targets that mimic nature’s resilience.

In this episode, you’ll learn:

- How gene therapies in animals improve endurance, recovery, frailty, and lifespan

- What hibernating animals and high-performance species teach about metabolism and resilience

- How AI and comparative genomics accelerate drug discovery and improve translational success

- Common misconceptions about translating animal biology to human health

- Future priorities in longevity research, including regenerative biology and disease resistance

If you want to understand how comparative biology and cutting-edge therapies are unlocking new pathways to enhance human healthspan, this episode connects science from the animal kingdom with actionable insights for human longevity.

Subscribe for weekly episodes that explore longevity science, preventative medicine, and the systems shaping how we live longer and better.

______________________

Hosts:

Phil Newman: ⁠⁠https://qrco.de/bgXpNY

Nina Patrick: ⁠⁠https://qrco.de/bgXpKn

______________________

Timestamps:

00:00:00 Why animals matter in aging research

00:02:18 Limits of traditional mouse models

00:04:52 Cancer resistance in large mammals

00:07:31 Hibernation and metabolic shutdown

00:10:06 Extreme physiology as a longevity map

00:12:44 Disease model vs wellness model

00:15:28 Reversible damage in nature

00:18:10 Translating animal traits to humans

00:21:37 Genomics and comparative mapping

00:24:12 Early medical proof points

00:28:03 AI and aging pathway discovery

00:32:22 Hypoxia and cardiometabolic recovery

00:37:12 FGF21 and metabolic crossover

00:42:25 Reversing vs preventing aging damage

00:49:05 Biologics and gene therapy future